Business
One World Cannabis to Offer New Alternative Treatment for Chronic Pain in Light Of FDA's NSAIDs Warning
One World Cannabis to Offer New Alternative Treatment for Chronic Pain in Light Of FDA's NSAIDs Warning.
About this update from Owc Pharmaceutical Research Corp
[{"type":"text","content":"\n\n\n\nOne World Cannabis to Offer New Alternative Treatment for Chronic Pain in Light Of FDA's NSAIDs Warning\n\n\n\n\n\nOne World Cannabis to Offer New Alternative Treatment for Chronic Pain in Light Of FDA's NSAIDs Warning\nOWC's Research & Development For New Chronic Pain Treatments Occurs As FDA Calls To Increase Existing Heart Attack And Stroke Warnings For NSAIDs\nPR Newswire\nPETACH TIKVA, Israel, July 15, 2015\n\n\n\nPETACH TIKVA, Israel, July 15, 2015 /PRNewswire/ --\n\nOWC Pharmaceutical Research Corp. (OTCQB: OWCP), an Israeli-based developer of cannabinoid-based therapies targeting a variety of different indications, is offering new and alternative hope to patients diagnosed with chronic pain. The company's wholly owned subsidiary, One World Cannabis Ltd., has already filed two provisional patent applications with the USPTO related to the development of two unique formulations that include cannabis extracts and a new delivery system to treat fibromyalgia and migraines, and has begun researching and developing new cannabis-based therapies to help alleviate the suffering of patients experiencing enduring pain.\n\n     (Logo: http://photos.prnewswire.com/prnh/20150311/734965-a )\n\n\n     (Logo: http://photos.prnewswire.com/prnh/20150311/734965-b )\n\n\nThe news comes about after the FDA recently announced to increase existing heart attack and stroke warnings for both over-the-counter and prescription non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs), which are typically used to treat chronic pain. The cannabis-based novel treatment employed by One World Cannabis could be an alternative to NSAIDs to treat long-lasting pain and fever from many different long- and short-term medical conditions. In addition, the cannabis-based treatment will provide physicians, as well as patients, with the ability to control and administrate optimal dosage, thus offering an alternative to current delivery systems that are not acceptable to scientists and physicians, such as smoking marijuana, edibles and oil extracts with no substantial dosage control.\n\n\"Chronic pain represents an emerging public health issue of massive proportions,\" said Dr. Yehuda Baruch, Director of Research and Regulatory Affairs,\" In light of the latest FDA calling on NSAIDs makers, One World Cannabis be...